Strengthen Restrictions On Off-label Promotion By Pharmaceutical Companies, Researchers Urge

Researchers are asking for tougher penalties and fines for pharmaceutical companies that market drugs for "off label" promotion, according to a new study. Researchers describe ways that the pharmaceutical industry uses marketing to encourage "the unmonitored, potentially dangerous use of drugs by patients for whom risks and benefits are unknown."

Read the whole article on Science Daily

More from Science Daily